Shockwave has been making waves this summer! As you dive into this edition of the PulsePoint Newsletter, you’ll see that JACC: Cardiovascular Interventions published a trilogy of peer-reviewed publications highlighting Shockwave’s MOA, a pooled analysis of the 4 Disrupt CAD studies, and Disrupt PAD lll. Dive deeper and you’ll discover the incredible 10-webinar series called Calcium Masterclass that was launched at the beginning of the quarter. Explore how Shockwave was granted transitional pass-through reimbursement for Coronary IVL and proposed additional payment for hospital in-patient Coronary IVL cases performed in the United States. This PulsePoint has a lot to cover – recap the rest of the events and milestones from an exciting last quarter. But as you relax on your vacation, always stay on the pulse!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Read More
Topics:
Coronary IVL,
IVL Case,
Peripheral IVL,
IVL Technology,
Coronary Cases,
Peripheral Cases,
Shockwave C2,
Shockwave M5,
Shockwave S4,
PulsePoint Newsletter,
Coronary IVL - U.S.
Acute recoil is a phenomenon in small arteries, such as those below-the-knee (BTK), when there is a significant reduction in luminal gain within just a few minutes after balloon angioplasty. Since the goal of BTK angioplasty is to maximize distal flow in order to heal wounds, recoil is a significant problem. As a result, reducing the incidence of acute recoil should be an important goal in improving BTK treatment.
Read More
Topics:
Peripheral IVL,
Peripheral Clinical Data,
Shockwave S4
This Catalyst post is the first in a new series – Clinical Corner with Suzanne Wallace – who is Shockwave’s Director of Medical Education and Scientific Communication. As a board certified nurse practitioner with a post-masters degree in family practice and master of science in nursing, specializing in emergency and critical care, Suzanne has spent the majority of her career caring for patients with cardiovascular disease. She will share her perspective and expertise on current IVL clinical topics while recapping meetings, trainings, and publications. We hope you find her insights beneficial in your daily practice! And if you ever want to get in touch with her, please feel free to reach out to her directly at swallace@shockwavemedical.com.
Read More
Topics:
Peripheral Cases,
PAD Applications - BTK,
PAD Applications - CLI,
Peripheral Clinical Data,
Clinical Corner with SW,
Shockwave S4
VIVA is always one of the best peripheral meetings every year, and we’re especially excited this year because we’ve got something new to show you: Shockwave S4.
Read More
Topics:
Peripheral Conferences,
Shockwave S4
The experience with Intravascular Lithotripsy in a wide variety of peripheral lesions continues to grow.
Critical limb ischemia (CLI) is the most advanced form of peripheral artery disease and often involves stenoses in calcified below-the-knee (BTK) arteries.
Read More
Topics:
Peripheral Cases,
PAD Applications - BTK,
PAD Applications - CLI,
Shockwave S4
